[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]
Maria Tablado MA.
europepmc +1 more source
Introduction of the dengue vaccine in Brazil: the importance of a strengthened Unified Health System in confronting arboviruses. [PDF]
Maciel ELN +8 more
europepmc +1 more source
Prevalence of self-medication among pregnant women attending a public hospital in Cartagena, Colombia, 2023–2024 [PDF]
Bello Trujillo AM +6 more
europepmc +1 more source
Farmacovigilancia hospitalaria
En la práctica clínica existen varios factores que dificultan la detección de las reacciones adversas producidas por medicamentos. La farmacovigilancia es utilizada para la prevención de riesgos de los medicamentos en los seres humanos y para evitar los ...
Ana Julia García Milián +3 more
doaj
[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [PDF]
Saza-Londoño W +7 more
europepmc +1 more source
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. [PDF]
Rodríguez-Tanta LY +5 more
europepmc +1 more source
Farmacovigilancia de medicamentos cubanos en revistas médicas nacionales
Introducción: publicar en revistas médicas nacionales las reacciones adversas observadas con medicamentos patentados en Cuba permite a los profesionales cubanos mayor acceso a la información; la magnitud de esta actividad no se conoce.
María Aida Cruz Barrios +4 more
doaj
Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases. [PDF]
Rachwal O +8 more
europepmc +1 more source
Signals of disproportionate reporting of events supposedly attributable to COVID-19 vaccines in children and adolescents: case-non-case study, Brazil, 2022. [PDF]
Silva RMA +5 more
europepmc +1 more source
Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]
Caffaratti M +9 more
europepmc +1 more source

